| Laboratory analyses
Upon admission, fasting blood samples of patients were collected from cubital veins into EDTA-containing tubes. The concentrations of serum total cholesterol (TC), triglyceride (TG), high-density lipoprotein cholesterol (HDL-C), apolipoprotein B (apoB), apolipoprotein A (apoA), and LDL-C were measured using automatic biochemistry analyzer (Hitachi 7150, Tokyo, Japan). Lp(a) level was determined using an immunoturbidimetric method [LASAY Lp(a) auto; SHIMA Laboratories] as previously described, 12 with its normal reference value less than 300 mg/L. Lp(a) year score was calculated as Lp(a) level multiplying the patient's age. 
| Severity of CAD
The diagnosis of CAD was defined as the presence of coronary lesions ≥50% in at least one major coronary artery assessed using CAG analyzed by at least two experienced interventional physicians. The severity of coronary atherosclerosis was quantified using
Gensini score (GS), which assigning the severity score based on the degree and location of stenosis. In detail, the narrowing was scored as 1 point for 1%-25%, 2 points for 26%-50%, 4 points for 51%-75%,
8 points for 76%-90%, 16 points for 91%-99%, and 32 points for 100% occluded artery. Then, the score was multiplied by a coefficient, indicating the functional significance of each segment. The coefficient was as follows: 5 for left main coronary artery (LM), 2.5
for proximal left anterior descending artery (LAD) and proximal left circumflex artery (LCX), 1.5 for middle LAD, 1.0 for distal LAD, mid-distal LCX and right coronary artery (RCA), and 0.5 for residual major segments. 13 
| Carotid ultrasound examination
Bilateral carotid arteries of each patient were examined by two experienced operators who were blind to the clinical characteristics of the patients using 128 System (Acuson, Mountain View, CA, USA) with a high-resolution 7.5-10.0 MHz transducer. Intima-media thickness (IMT) was measured on the proximal and distal common carotid artery as well as the bifurcation in both left and right carotid arteries.
The mean cIMT represented the average value of IMT in bilateral arteries. Carotid plaque was defined as a local enlargement of the IMT of more than 50% of the surrounding IMT, or the IMT was above 1.5 mm, and was documented as present or absent.
| Statistical analysis
The statistical analysis was performed with SPSS version 21.0 software (SPSS Inc., Chicago Illinois, USA). Continuous variables were presented as mean ± standard deviation (SD) if normally distributed and analyzed with analysis of variance (ANOVA). Otherwise, median (Q1-Q3 quartiles) represented abnormal variables, and differences among groups
were assessed using Mann-Whitney U test. Categorical variable,
shown as number (percentage), were analyzed using chi-square test.
The correlation of Lp(a) with GS and cIMT was assessed by Spearman's or Pearson's correlation analysis. Multivariable logistic regression analysis was performed to determine the odds ratios (OR) and 95% confidential interval (CI) of Lp(a) and CAD as well as carotid plaque, adjusted by potential confounding factors. A P-value <.05 was considered as significantly different.
| RE SULTS

| Baseline characteristics
The clinical characteristics of the study population are shown in 
| Association between Lp(a) and CAD
Patients with CAD had significantly higher level of Lp(a) and Lp(a) year score as well as prevalence of Lp(a) ≥ 300 mg/L (all P < .05)
as shown in Table 1 . In turn, as shown in Figure 1 , patients with Lp(a) ≥ 300 mg/L had higher prevalence of CAD (69.7% vs 50%, P = .016) and GS (median 27 vs 3, P = .006) significantly. Furthermore, using Spearman's correlation analysis (Table 3) , we observed that there were positive correlations between GS with Lp(a) and Lp(a) year score (r = .223, P = .01; r = .276, P = .001, respectively). After adjusting confounding risk factors including age, male sex, BMI, family history of CAD, statin, HT, DM, smoke, and HDL-C, multivariable regression analysis (Table 4) 
| Association between Lp(a) and carotid lesions
Patients with carotid plaques did not have significant differences regarding Lp(a) and Lp(a) year score nor the prevalence of Lp(a) ≥ 300 mg/L (P = .675, P = .122 and P = .833, respectively)
as shown in Table 2 . The presence of carotid plaque between patients with high or low level of Lp(a) also did not differ significantly 
| D ISCUSS I ON
The present study, for the first time, indicated that Lp(a) level was as- 22 Although the data were generally consistent with them, several key points should be emphasized with regard to our study. Compared with its hazardous role in the development of CAD, the associations of Lp(a) with carotid IMT and plaques are still controversial. Some previous studies found no association between 30 However, their study did not provide information regarding CAD. In addition, similar to prior study, we have found that apoB was associated with the presence of carotid plaques. 31 Unquestionably, more studies about the irrelevant results between Lp(a) and carotid lesions in our observation may be needed considering our small sample size.
In fact, we firstly queried that whether Lp(a) played equally important roles in the presence of coronary and carotid lesions according to reviewing previous publications. Unfortunately, there has been no relevant data available in patients with HeFH before as far as we know. Currently, we found that Lp(a) level was associated with coronary but not carotid atherosclerosis. The exact mechanism with regarding this disparity in carotid and coronary arteries is unknown, while a large number of studies have suggested that Lp(a) exerts atherogenic property due to its cholesterol-rich particle, the prothrombotic, and proinflammatory effects. 32 In other words, in spite of the similarities between coronary and carotid atherosclerosis including sharing partial conventional risk factors, the exact correspondence between the two arteries remains unclear and thus the specific effects of Lp(a) on coronary and carotid arteries may be different. 33 Therefore, how Lp(a) was involved in the pathogenic mechanism of coronary and carotid atherosclerosis needs to be further established.
It is imperative to note several limitations in the present study when interpreting the results. First, our study was a crosssectional study and the association between Lp(a) and carotid atherosclerosis needs further robust evidence from prospective studies. Second, this was a single-center study with relatively small sample size.
In conclusion, the present study suggested that Lp(a) level was associated with the presence and severity of CAD but not with carotid atherosclerosis in patients with HeFH. Notwithstanding the mechanism remains uncertain, the current study may provide further insights into the role of Lp(a) in the development of different atherosclerosis in patients with FH and help improve future specific preventions. 
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